Discover how a groundbreaking cancer immunotherapy using localized Ad-ISF35 injections triggers system-wide immune responses against non-Hodgkin's lymphoma.
Discover how metabolic glycan labeling uses sugar-coated nanotechnology to mark cancer cells for immune destruction, revolutionizing cancer immunotherapy.